CLINICAL ENZYMOLOGY
Dr. Mohammad Azharuddin Mulla
Vallabhbhai Patel Chest Institute Delhi
vDIAGNOSTIC
vTHERAPEUTIC
vANALYTICAL USES OF ENZYMES
CLINICAL ENZYMOLOGY
DIAGNOSTIC USES THERAPEUTIC USES ANALYTICAL/LAB USES
Ø Diagnosis
Ø Monitoring
Ø Treatment Ø Laboratory Analysis
ENZYMES
PLASMA FUNCTIONAL
ENZYMES
PLASMA NON-FUNCTIONAL
ENZYMES
• Plasma Specific
• Most are synthesized in liver, released into the plasma
• Ex:
ü Coagulation factors
ü Complement factors
ü Lipoprotein Lipase
ü Ceruloplasmin
ü Renin
ü Cholinesterase
• Plasma Non-Specific
• Derived from cells of organs and tissues
• Ex:
ü Creatine Kinase
ü Lactate dehydrogenase
ü Alkaline Phosphatase
ü Aspartate Aminotransferase (AST)
ü Alanine Transaminase (ALT)
ü Etc….
Plasma Non functional Enzymes
Disease states of tissues
Hypoxic of infective insults
Excessive synthesis or
induction with
overflow into plasma
Vigorous Excercise
Decreased renal clearance
DIAGNOSTIC USES OF ENZYMES
CARDIAC
PANCREAS
PROSTATE
BONE
LIVER
BILIARY TRACT
MUSCLE
ü AMYLASE
ü LIPASE
ü ACP,
ü PSA
ü ALP: PRE !
ü CK-MB
ü AST
ü LDH
ü AST
ü ALP
ü GGT
ü ALT
ü 5’NT
ü GGT
ü CK-MM
ü AST
ü ALDOLASE
OTHERS
ü G-6-PD
ü CHOLINESTERASE
ü CERULOPLASMIN
ENZYME PROFILE IN CARDIAC DISEASE
• Detection of AMI and minor myocardial injury
ENZYME PROFILE IN CARDIAC DISEASE
Non Enzymatic/Enzymatic Cardiac markers:
ENZYME PROFILE IN LIVER DISEASES
Markers of
Hepatocellular Injury
Markers of
Cholestasis
v Alanine Transaminase (ALT)/SGPT
v Aspartate Transaminase (AST)/SGOT
v Alkaline Phosphatase (ALP)
v !-glutamyl transferase (GGT)
v 5’ Nucleotidase
ENZYME PROFILE IN LIVER DISEASES
ALANINE TRANSMINASE ASPARTATE TRANSAMINASE
Site Liver- Cytosol Liver, Heart, Skeletal muscle, Cytosol,
Mitochondria
Normal ref range 5-40 U/L 5-35 U/L
Marked Increase (300-1000 U/L) Severe viral hepatitis, toxic hepatitis Severe hepatitis, toxic hepatitis
Mild to Mod Increase (50-100 UL) Biliary tract obst, alcoholic hepatitis Alcoholic hepatitis, Chronic active
hepatitis, hepatic metastasis
Non Hepatic conditions ----- MI, skeletal muscle disorders
Both ALT and AST are increased in Liver disease, but ALT>AST
Normal AST/ALT ration is <1
Ration >2 is seen in alcoholic hepatitis, because
ü due to reduction of hepatic AST and
ü increased release of AST from mitochondria
Alkaline Phosphatase: ALP- Markers of Obstructive liver disease
Isoenzymes Site Condition
Alpha-1 ALP Epithelial cells of biliary
canaliculi
Obstructive Jaundice
Alpha -2 (Heat Liable) Hepatic cells Hepatic disease
Alpha-2 (Heat stable) Placental origin Pregnancy
Pre-Beta Bone Bone diseases
Gamma Intestinal cells Ulcerative colitis
Leucocyte ALP CML (↓) Lymphomas (↑)
Normal ref range of ALP: 30-115 U/L
Moderate(2-3 times)
ü Hepatic diseases
ü Infective hepatitis
ü Alcoholic hepatitis
ü Hepatocellular carcinoma
Very High (10-12 times)
ü Extra hepatic Obstruction
ü Obstructive jaundice
ü Intra-hepatic cholestasis
ü Viral hepatitis
ü Drugs (chlorpromazine)
Drastically High (10-25 times)
ü Bone diseases
ü Paget’s disease
ü Rickets, Osteomalacia
ü Osteoblastoma
ü Mets Ca of bone
Gamma-Glutamyl transferase: GGT- Markers of Obstructive liver disease
üIt is seen in Liver, Kidney, Intestine
üRef range: 5-40 U/L
üSensitive biomarker for the recognition of alcohol abuse and ALD
even when other LFT are within normal limits
üSignificantly increased in obstructive jaundice
5’ Nucleotidase -Markers of Obstructive liver disease
üEctoenzyme present on cell membrane
üRef range: 2-10 U/L
üModerately increased in biliary obstruction
üMore specific for obstructive liver disease
ALP GGT Condition
Mild or moderately elevated Elevated Hepatic or Biliary disease
Highly elevated Elevated Biliary disease only
Elevated Normal Bone disease
Normal Elevated Alcohol abuse
Enzyme profile in Muscle disease
Creatine Kinase
(CK-MM)
Aspartate Transaminase Aldolase
Marked increased in
Muscle disease
↑ in muscle disease
Not specific
Earliest enzyme to rise but
not specific
Enzyme Profile in Pancreatic disease
AMYLASE LIPASE (More specific than Amylase)
Produced by Pancreas (P-type) & Salivary glands (S-
type)
Present in Pancreatic secretions
Normal ref range: 50-120 U/L Normal Ref range: 0.2- 1.0 U/L
↑ in Acute Pancreatitis (1000 times) ↑ Acute Pancreatitis
Peak: B/w 5-12 hours after onset
Returns to normal within 2-4 days after acute phase
has subsided
Persists for 7-14 days
Elevated longer than amylase
Moderate ↑: Chronic Pancreatitis, Mumps, Pancreatic
duct obstruction
Not increased in mumps
Lipase estimation has advantages over amylase
Moderate ↑ in Ca pancreas, Biliary disease
Enzyme Profile in Bone diseases
vALP: pre-!
üDrastically high (10-25 times)
üBone diseases
• Paget’s disease
• Rickets, Osteomalacia
• Osteoblastoma
• Metastatic carcinoma of bone
Enzyme profile in Prostate disease
vACID PHOSPHATASE:
üHydrolyses Phosphoric acid ester at pH between 4 & 6
üSecreted by prostate cells, RC, platelets and WBC
üProstate isoenzyme is inactivated by tartaric acid
üNormal ref range ACP: 0-0.6 U/L
üTotal ACP:
§ ↑ in prostate cancer
§ ↑↑ in bone metastasis of prostate cancer
• Useful for follow up of treatment of prostate cancers
• Prostate acid phosphatase: Important tumor marker
Enzyme profile in Prostate disease
vPROSTATE SPECIFI ANTIGEN:
• It is not an enzyme but Glycoprotein, with mild protease activity
• Produced from secretory epithelium of prostate gland
• Normally secreted into seminal fluidà liquefaction of seminal
coagulum
• Reliable marker for prostate cancer
• PSA is a tumor marker: detect stage & monitor treatment of prostate
cancer
• PSA is better predictor than prostatic acid phosphatase for diagnosis of
prostate cancer
Other Enzymes
vCHOLINESTERASE
• Acetylcholinesterase (True ChE/ Type I ChE)
+ Nerve endings/RBCs
• ChE in RBCs: determine exposure in person working with
organophosphorus insecticides (Parathion)
• Irreversibly inhibit ChE in RBCs
vPSEUDOCHOLINESTERASE:
• (Type II ChE: Nonspecific: hydrolyze acyl esters)
+ Liver cells
vGLUCOSE-6-PHOSPHATE DEHYDROGENASE:
• Enzyme of HMP pathway
• ↓ G-6-P-D associated with drug induced hemolytic anemia
vCERULOPLAMIN:
• Ferroxidase
• Acute phase protein
• ↑in all inflammatory conditions, collagen diseases, malignancies
• Normal Ref range: 25-50 mg/dL
• <20mg/dL: pathognomic of Wilson’s hepatolenticular degeneration
• Copper toxicity
Enzymes in other body fluids:
ENZYME CLINICAL SIGNIFICANCE
Adenosine deaminase (ADA) in pleural fluid ↑↑ Tubercular pleural effusion but not in Malignant
effusion
LDH in pleural/ascitic fluid ↑↑ Malignant tumor ( Not diagnostic, as enzyme is
not tissue specific)
Therapeutic Uses:
ENZYME USES
Streptokinase / Urokinase Lysis of intravascular blood clot
Recombinant tissue prothrombin activator (rtPA) Lysis of clot (esp. cerebrovascular thrombolysis)
Asparaginase Acute Lymphoblastic Leukemia
Streptodornase DNAse, applied locally
Pancreatin (trypsin & Lipase) Pancreatic insufficiency
⍺-1 antitrypsin AAT deficiency, Emphysema
Papain Anti-inflammatory agent
Analytical uses of enzymes
Enzyme as reagent Uses
Glucose oxidase and peroxidase Glucose
Cholesterol oxidase and peroxidase Cholesterol
Urease Urea
Uricase Uric Acid
Hexokinase and G-6-PD Creatine Kinase
Lipase, Glycerol phosphate dehydrogenase Triacylglycerol
Lactate dehydrogenase Lactate
Alcohol dehydrogenase Ethanol
Analytical uses:
vGenetic engineering
• Restriction endonucleasesà Gene transfer, DNA fingerprinting
• Taq DNA polymeraseà Polymerase chain reaction
vIndustrial Uses:
Enzymes Uses
Renin Cheese preparation
Glucose Isomerase Production of high fructose syrup
Alpha amylase Food industry
Proteases Washing Powder
THANK YOU

Equivalent Mass and Its Applications practical ppt

  • 1.
    CLINICAL ENZYMOLOGY Dr. MohammadAzharuddin Mulla Vallabhbhai Patel Chest Institute Delhi
  • 2.
  • 3.
    CLINICAL ENZYMOLOGY DIAGNOSTIC USESTHERAPEUTIC USES ANALYTICAL/LAB USES Ø Diagnosis Ø Monitoring Ø Treatment Ø Laboratory Analysis
  • 4.
    ENZYMES PLASMA FUNCTIONAL ENZYMES PLASMA NON-FUNCTIONAL ENZYMES •Plasma Specific • Most are synthesized in liver, released into the plasma • Ex: ü Coagulation factors ü Complement factors ü Lipoprotein Lipase ü Ceruloplasmin ü Renin ü Cholinesterase • Plasma Non-Specific • Derived from cells of organs and tissues • Ex: ü Creatine Kinase ü Lactate dehydrogenase ü Alkaline Phosphatase ü Aspartate Aminotransferase (AST) ü Alanine Transaminase (ALT) ü Etc….
  • 5.
    Plasma Non functionalEnzymes Disease states of tissues Hypoxic of infective insults Excessive synthesis or induction with overflow into plasma Vigorous Excercise Decreased renal clearance
  • 6.
    DIAGNOSTIC USES OFENZYMES CARDIAC PANCREAS PROSTATE BONE LIVER BILIARY TRACT MUSCLE ü AMYLASE ü LIPASE ü ACP, ü PSA ü ALP: PRE ! ü CK-MB ü AST ü LDH ü AST ü ALP ü GGT ü ALT ü 5’NT ü GGT ü CK-MM ü AST ü ALDOLASE OTHERS ü G-6-PD ü CHOLINESTERASE ü CERULOPLASMIN
  • 7.
    ENZYME PROFILE INCARDIAC DISEASE • Detection of AMI and minor myocardial injury
  • 8.
    ENZYME PROFILE INCARDIAC DISEASE
  • 9.
  • 10.
    ENZYME PROFILE INLIVER DISEASES Markers of Hepatocellular Injury Markers of Cholestasis v Alanine Transaminase (ALT)/SGPT v Aspartate Transaminase (AST)/SGOT v Alkaline Phosphatase (ALP) v !-glutamyl transferase (GGT) v 5’ Nucleotidase
  • 11.
    ENZYME PROFILE INLIVER DISEASES ALANINE TRANSMINASE ASPARTATE TRANSAMINASE Site Liver- Cytosol Liver, Heart, Skeletal muscle, Cytosol, Mitochondria Normal ref range 5-40 U/L 5-35 U/L Marked Increase (300-1000 U/L) Severe viral hepatitis, toxic hepatitis Severe hepatitis, toxic hepatitis Mild to Mod Increase (50-100 UL) Biliary tract obst, alcoholic hepatitis Alcoholic hepatitis, Chronic active hepatitis, hepatic metastasis Non Hepatic conditions ----- MI, skeletal muscle disorders Both ALT and AST are increased in Liver disease, but ALT>AST Normal AST/ALT ration is <1 Ration >2 is seen in alcoholic hepatitis, because ü due to reduction of hepatic AST and ü increased release of AST from mitochondria
  • 12.
    Alkaline Phosphatase: ALP-Markers of Obstructive liver disease Isoenzymes Site Condition Alpha-1 ALP Epithelial cells of biliary canaliculi Obstructive Jaundice Alpha -2 (Heat Liable) Hepatic cells Hepatic disease Alpha-2 (Heat stable) Placental origin Pregnancy Pre-Beta Bone Bone diseases Gamma Intestinal cells Ulcerative colitis Leucocyte ALP CML (↓) Lymphomas (↑)
  • 13.
    Normal ref rangeof ALP: 30-115 U/L Moderate(2-3 times) ü Hepatic diseases ü Infective hepatitis ü Alcoholic hepatitis ü Hepatocellular carcinoma Very High (10-12 times) ü Extra hepatic Obstruction ü Obstructive jaundice ü Intra-hepatic cholestasis ü Viral hepatitis ü Drugs (chlorpromazine) Drastically High (10-25 times) ü Bone diseases ü Paget’s disease ü Rickets, Osteomalacia ü Osteoblastoma ü Mets Ca of bone
  • 14.
    Gamma-Glutamyl transferase: GGT-Markers of Obstructive liver disease üIt is seen in Liver, Kidney, Intestine üRef range: 5-40 U/L üSensitive biomarker for the recognition of alcohol abuse and ALD even when other LFT are within normal limits üSignificantly increased in obstructive jaundice
  • 15.
    5’ Nucleotidase -Markersof Obstructive liver disease üEctoenzyme present on cell membrane üRef range: 2-10 U/L üModerately increased in biliary obstruction üMore specific for obstructive liver disease
  • 16.
    ALP GGT Condition Mildor moderately elevated Elevated Hepatic or Biliary disease Highly elevated Elevated Biliary disease only Elevated Normal Bone disease Normal Elevated Alcohol abuse
  • 17.
    Enzyme profile inMuscle disease Creatine Kinase (CK-MM) Aspartate Transaminase Aldolase Marked increased in Muscle disease ↑ in muscle disease Not specific Earliest enzyme to rise but not specific
  • 18.
    Enzyme Profile inPancreatic disease AMYLASE LIPASE (More specific than Amylase) Produced by Pancreas (P-type) & Salivary glands (S- type) Present in Pancreatic secretions Normal ref range: 50-120 U/L Normal Ref range: 0.2- 1.0 U/L ↑ in Acute Pancreatitis (1000 times) ↑ Acute Pancreatitis Peak: B/w 5-12 hours after onset Returns to normal within 2-4 days after acute phase has subsided Persists for 7-14 days Elevated longer than amylase Moderate ↑: Chronic Pancreatitis, Mumps, Pancreatic duct obstruction Not increased in mumps Lipase estimation has advantages over amylase Moderate ↑ in Ca pancreas, Biliary disease
  • 19.
    Enzyme Profile inBone diseases vALP: pre-! üDrastically high (10-25 times) üBone diseases • Paget’s disease • Rickets, Osteomalacia • Osteoblastoma • Metastatic carcinoma of bone
  • 20.
    Enzyme profile inProstate disease vACID PHOSPHATASE: üHydrolyses Phosphoric acid ester at pH between 4 & 6 üSecreted by prostate cells, RC, platelets and WBC üProstate isoenzyme is inactivated by tartaric acid üNormal ref range ACP: 0-0.6 U/L üTotal ACP: § ↑ in prostate cancer § ↑↑ in bone metastasis of prostate cancer • Useful for follow up of treatment of prostate cancers • Prostate acid phosphatase: Important tumor marker
  • 21.
    Enzyme profile inProstate disease vPROSTATE SPECIFI ANTIGEN: • It is not an enzyme but Glycoprotein, with mild protease activity • Produced from secretory epithelium of prostate gland • Normally secreted into seminal fluidà liquefaction of seminal coagulum • Reliable marker for prostate cancer • PSA is a tumor marker: detect stage & monitor treatment of prostate cancer • PSA is better predictor than prostatic acid phosphatase for diagnosis of prostate cancer
  • 22.
    Other Enzymes vCHOLINESTERASE • Acetylcholinesterase(True ChE/ Type I ChE) + Nerve endings/RBCs • ChE in RBCs: determine exposure in person working with organophosphorus insecticides (Parathion) • Irreversibly inhibit ChE in RBCs vPSEUDOCHOLINESTERASE: • (Type II ChE: Nonspecific: hydrolyze acyl esters) + Liver cells
  • 23.
    vGLUCOSE-6-PHOSPHATE DEHYDROGENASE: • Enzymeof HMP pathway • ↓ G-6-P-D associated with drug induced hemolytic anemia
  • 24.
    vCERULOPLAMIN: • Ferroxidase • Acutephase protein • ↑in all inflammatory conditions, collagen diseases, malignancies • Normal Ref range: 25-50 mg/dL • <20mg/dL: pathognomic of Wilson’s hepatolenticular degeneration • Copper toxicity
  • 26.
    Enzymes in otherbody fluids: ENZYME CLINICAL SIGNIFICANCE Adenosine deaminase (ADA) in pleural fluid ↑↑ Tubercular pleural effusion but not in Malignant effusion LDH in pleural/ascitic fluid ↑↑ Malignant tumor ( Not diagnostic, as enzyme is not tissue specific)
  • 27.
    Therapeutic Uses: ENZYME USES Streptokinase/ Urokinase Lysis of intravascular blood clot Recombinant tissue prothrombin activator (rtPA) Lysis of clot (esp. cerebrovascular thrombolysis) Asparaginase Acute Lymphoblastic Leukemia Streptodornase DNAse, applied locally Pancreatin (trypsin & Lipase) Pancreatic insufficiency ⍺-1 antitrypsin AAT deficiency, Emphysema Papain Anti-inflammatory agent
  • 28.
    Analytical uses ofenzymes Enzyme as reagent Uses Glucose oxidase and peroxidase Glucose Cholesterol oxidase and peroxidase Cholesterol Urease Urea Uricase Uric Acid Hexokinase and G-6-PD Creatine Kinase Lipase, Glycerol phosphate dehydrogenase Triacylglycerol Lactate dehydrogenase Lactate Alcohol dehydrogenase Ethanol
  • 29.
    Analytical uses: vGenetic engineering •Restriction endonucleasesà Gene transfer, DNA fingerprinting • Taq DNA polymeraseà Polymerase chain reaction vIndustrial Uses: Enzymes Uses Renin Cheese preparation Glucose Isomerase Production of high fructose syrup Alpha amylase Food industry Proteases Washing Powder
  • 30.